Table 2.
2003–2004 n (%) |
2014–2015 n (%) |
|
---|---|---|
FBN1 mutation | 55 (87) | 58 (92) |
Patients on β‐blockers and/or other antihypertensive agents | 32 (51) | 46 (73) |
Patients with aortic surgery before inclusion in 2003 | 24 (38) | |
Patients with new cardiovascular events | 32 (51) | |
Patients with aortic surgery during follow‐up | 24 (38) | |
Total patients who have undergone aortic surgery | 37 (59) |
N = 63 (47 survivors and 16 deceased), 42 (67%) women.